BR112012013041A2 - biomarcador específico para melanoma - Google Patents
biomarcador específico para melanomaInfo
- Publication number
- BR112012013041A2 BR112012013041A2 BR112012013041A BR112012013041A BR112012013041A2 BR 112012013041 A2 BR112012013041 A2 BR 112012013041A2 BR 112012013041 A BR112012013041 A BR 112012013041A BR 112012013041 A BR112012013041 A BR 112012013041A BR 112012013041 A2 BR112012013041 A2 BR 112012013041A2
- Authority
- BR
- Brazil
- Prior art keywords
- melanoma
- specific biomarker
- acid sequence
- specific
- biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 4
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 108700005856 engrailed 2 Proteins 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000012800 visualization Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0921329.9A GB0921329D0 (en) | 2009-12-04 | 2009-12-04 | Biomarker |
| PCT/GB2010/001334 WO2011067549A1 (en) | 2009-12-04 | 2010-07-13 | Melanoma specific biomarker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012013041A2 true BR112012013041A2 (pt) | 2016-10-11 |
Family
ID=41641989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012013041A BR112012013041A2 (pt) | 2009-12-04 | 2010-07-13 | biomarcador específico para melanoma |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120263654A1 (https=) |
| EP (1) | EP2507384A1 (https=) |
| JP (1) | JP2013512668A (https=) |
| CN (1) | CN102791878A (https=) |
| AU (1) | AU2010326433A1 (https=) |
| BR (1) | BR112012013041A2 (https=) |
| CA (1) | CA2782034A1 (https=) |
| GB (1) | GB0921329D0 (https=) |
| IL (1) | IL219834A0 (https=) |
| IN (1) | IN2012DN04381A (https=) |
| MX (1) | MX2012006229A (https=) |
| RU (1) | RU2012121096A (https=) |
| WO (1) | WO2011067549A1 (https=) |
| ZA (1) | ZA201203517B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0913578A2 (pt) | 2008-05-14 | 2017-06-06 | Dermtech Int | diagnose de melanoma e lentigo solar por análise de ácido nucléico |
| US20150005184A1 (en) * | 2013-06-28 | 2015-01-01 | Dermtech International | Diagnosis of melanoma by nucleic acid analysis |
| WO2019161126A1 (en) | 2018-02-14 | 2019-08-22 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
| US11035849B2 (en) | 2015-04-13 | 2021-06-15 | The Translational Genomics Research Institute | Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies |
| US11802305B2 (en) * | 2015-06-24 | 2023-10-31 | Oxford BioDynamics PLC | Detection processes using sites of chromosome interaction |
| KR101777085B1 (ko) * | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| WO2020198229A1 (en) | 2019-03-26 | 2020-10-01 | Dermtech, Inc. | Novel gene classifiers and uses thereof in skin cancers |
| RU2766739C1 (ru) * | 2021-04-12 | 2022-03-15 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Способ прогноза эффективности терапии меланомы |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2469089A1 (en) * | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| US20070154889A1 (en) * | 2004-06-25 | 2007-07-05 | Veridex, Llc | Methods and reagents for the detection of melanoma |
| US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| US7960110B2 (en) * | 2006-11-15 | 2011-06-14 | The Regents Of The University Of California | Detection of chromosomal region copy number changes to diagnose melanoma |
| GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
| WO2009131733A1 (en) * | 2008-04-21 | 2009-10-29 | The Trustees Of Columbia University In The City Of New York | Gab2 amplification in melanoma |
-
2009
- 2009-12-04 GB GBGB0921329.9A patent/GB0921329D0/en not_active Ceased
-
2010
- 2010-07-13 MX MX2012006229A patent/MX2012006229A/es not_active Application Discontinuation
- 2010-07-13 WO PCT/GB2010/001334 patent/WO2011067549A1/en not_active Ceased
- 2010-07-13 CN CN2010800550196A patent/CN102791878A/zh active Pending
- 2010-07-13 BR BR112012013041A patent/BR112012013041A2/pt not_active IP Right Cessation
- 2010-07-13 EP EP10742865A patent/EP2507384A1/en not_active Withdrawn
- 2010-07-13 JP JP2012541569A patent/JP2013512668A/ja active Pending
- 2010-07-13 RU RU2012121096/10A patent/RU2012121096A/ru not_active Application Discontinuation
- 2010-07-13 US US13/513,345 patent/US20120263654A1/en not_active Abandoned
- 2010-07-13 AU AU2010326433A patent/AU2010326433A1/en not_active Abandoned
- 2010-07-13 IN IN4381DEN2012 patent/IN2012DN04381A/en unknown
- 2010-07-13 CA CA2782034A patent/CA2782034A1/en not_active Abandoned
-
2012
- 2012-05-15 ZA ZA2012/03517A patent/ZA201203517B/en unknown
- 2012-05-16 IL IL219834A patent/IL219834A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0921329D0 (en) | 2010-01-20 |
| RU2012121096A (ru) | 2014-01-10 |
| JP2013512668A (ja) | 2013-04-18 |
| EP2507384A1 (en) | 2012-10-10 |
| IN2012DN04381A (https=) | 2015-08-07 |
| MX2012006229A (es) | 2012-06-19 |
| WO2011067549A1 (en) | 2011-06-09 |
| ZA201203517B (en) | 2013-02-27 |
| CA2782034A1 (en) | 2011-06-09 |
| US20120263654A1 (en) | 2012-10-18 |
| CN102791878A (zh) | 2012-11-21 |
| AU2010326433A1 (en) | 2012-06-07 |
| IL219834A0 (en) | 2012-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012013041A2 (pt) | biomarcador específico para melanoma | |
| EP4667583A3 (en) | Multiple tagging of long dna fragments | |
| HK1211260A1 (en) | Method and kit for nucleic acid sequencing | |
| AU2010315303A8 (en) | Quantitative Nuclease Protection Sequencing (qNPS) | |
| WO2016065349A3 (en) | Short non-coding protein regulatory rnas (sprrnas) and methods of use | |
| EP2351575A4 (en) | NEW USE OF GRS PROTEINS OR FRAGMENTS THEREOF | |
| BRPI0807132A2 (pt) | enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas | |
| BR112012008054A2 (pt) | domínios catalíticos de lisil oxidase e loxl2 | |
| WO2011106629A3 (en) | Modified proteins and methods of making and using same | |
| HK1223659A1 (zh) | 基於可多重标签的报告系统 | |
| EA201491159A1 (ru) | Способы и композиции для анализа ahasl генов в пшенице | |
| AR070717A1 (es) | Lipasas y usos de las mismas en la industria lactea | |
| EA201490534A1 (ru) | Способы мечения днк-кодированных библиотек | |
| WO2013181256A3 (en) | Novel pharmacogene single nucleotide polymorphisms and methods of detecting same | |
| BR112012011576A2 (pt) | dna de minicírculos superenrolados para aplicações de terapia genética | |
| WO2019094780A3 (en) | Non-coding rna for detection of cancer | |
| BR112017025785A2 (pt) | ?biossensor, enzima de glicose desidrogenase, enzima oxirredutase, polipeptídeo, composição ou kit, método de detecção de uma molécula alvo, método de diagnóstico de uma doença ou condição em um organismo, dispositivo de detecção, ácido nucleico isolado, construção gênica, célula hospedeira e método para produzir um biossensor? | |
| BR112014003877A2 (pt) | biomarcadores de micro-rna e métodos de uso dos mesmos | |
| BRPI0906090A2 (pt) | substrato para análise de uma enzima, molécula e método para detectar atividade enzimática . | |
| MX2011006773A (es) | Biomarcador. | |
| BR112013001863A2 (pt) | peptídeos com efeitos analgésicos e inibindo os canais asic. | |
| BR112014011937A2 (pt) | detecção altamente multiplexada quantitativa de ácidos nucléicos | |
| BRPI1007979A2 (pt) | Anticorpos anti-mst1r e usos dos mesmos | |
| BR112012010976A2 (pt) | biomarcadores de preteína secretória para expressão preotéica de alta eficiência | |
| BRPI1002094A2 (pt) | Utilização de pelo menos uma forma peptidica solúvel, e processos de triagem de ativos anti-idade e de caracterização da eficácia de um tratamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |